Trial intelligence / Profile preview

Addition of midazolam, paracetamol, tramadol or magnesium sulphate to ropivacaine for postoperative pain control in forearm surgery

IRCT20141209020258N168Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Nov 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of ropivacaine in postoperative pain (4 arms), sponsored by Arak University of Medical Sciences. Started Nov 2021; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20141209020258N168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call